IFNG and pachyonychia congenita: As far as IFNG was concerned, only the PC patients with higher levels (>1.0 pg/mL) had a mortality risk, which was about three times higher (HR = 2.95, 95% CL = 1.18–7.36) than that of patients with lower levels (Figure S2), resulting in significantly reduced OS.